A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy

Journal of Controlled Release

Volumn 184, Issue 1, 2014, Pages 20-27

  Miyabe, Hiroko ^a   Hyodo, Mamoru ^a   Nakamura, Takashi ^a   Sato, Yusuke ^a   Hayakawa, Yoshihiro ^b   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b AICHI INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Adjuvant; Anti tumor activity; C di GMP; Liposome

Indexed keywords

ANTIBIOTICS; CONTROLLED DRUG DELIVERY; CYTOLOGY; DIAGNOSIS; GLYCOPROTEINS; IMMUNE SYSTEM; LIPOSOMES; MOLECULES; SIGNAL TRANSDUCTION; T-CELLS; TARGETED DRUG DELIVERY; TUMORS;

ADJUVANT; ANTI-TUMOR ACTIVITIES; CANCER IMMUNOTHERAPY; INHIBITION OF TUMOR GROWTH; INNATE IMMUNE SYSTEMS; LIPOSOMAL DRUG DELIVERY SYSTEMS; PH-SENSITIVE LIPIDS; SCREENING EXPERIMENTS;

C (PROGRAMMING LANGUAGE);

ADENOSINE TRIPHOSPHATE; ADJUVANT; BETA INTERFERON; CD86 ANTIGEN; CHOLESTEROL; CYCLIC DI GUANOSINE PHOSPHATE; DINUCLEOTIDE; ENZYME INHIBITOR; LIPID; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOSPHATE; RNA HELICASE; UNCLASSIFIED DRUG; BIS(3',5')-CYCLIC DIGUANYLIC ACID; CANCER VACCINE; CYCLIC GMP; IMMUNOLOGICAL ADJUVANT; OVALBUMIN; PIPERIDINE DERIVATIVE; YSK05;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL LINE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; GROWTH INHIBITION; IN VITRO STUDY; INNATE IMMUNITY; MOUSE; NANOENCAPSULATION; NONHUMAN; PH; PRIORITY JOURNAL; TUMOR GROWTH; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FEMALE; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; NEOPLASMS; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CANCER VACCINES; CELL LINE; CELL LINE, TUMOR; CYCLIC GMP; FEMALE; IMMUNOTHERAPY; INTERFERON-BETA; LIPIDS; LIPOSOMES; MICE, INBRED C57BL; NEOPLASMS; OVALBUMIN; PIPERIDINES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR BURDEN;

EID: 84899553069     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.04.004     Document Type: Article

References (34)

1. I. Mellman, G. Coukos, and G. Dranoff Cancer immunotherapy comes of age Nature 480 7378 2011 480 488
2. E.J. Small, P.F. Schellhammer, C.S. Higano, C.H. Redfern, J.J. Nemunaitis, F.H. Valone, S.S. Verjee, L.A. Jones, and R.M. Hershberg Placebo-controlled Phase III trial of immunogenic therapy with Sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer J. Clin. Oncol. 24 19 2006 3089 3094
3. D.M. Pardoll The blockage of immune checkpoints in cancer immunotherapy Nat. Rev. Cancer 12 4 2012 252 264
4. P. Sharma, K. Wagner, J.D. Wolchok, and J.P. Allison Novel cancer immunotherapy agents with survival benefit: recent successes and next steps Nat. Rev. Cancer 11 11 2011 805 812
5. T.W. Dubensky Jr., and S.G. Reed Adjuvants for cancer vaccines Semin. Immunol. 22 3 2010 155 161
6. F. Civril, T. Deimling, C.C. de Olivia Mann, A. Ablasser, M. Moldt, G. Witte, V. Hornung, and K.P. Hopfner Structural mechanism of cytosolic DNA sensing by cGAS Nature 498 7454 2013 332 337
7. A. Ablasser, M. Goldeck, T. Cavlar, T. Deimling, G. Witte, I. Röhl, K.P. Hopfner, J. Ludwig, and V. Hornung cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING Nature 498 7454 2013 380 384
8. E.J. Diner, D.L. Burdette, S.C. Wilson, K.M. Monroe, C.A. Kellenberger, M. Hyodo, Y. Hayakawa, M.C. Hammond, and R.E. Vance The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING Cell Rep. 3 5 2013 1355 1361
9. P. Ross, H. Weinhouse, Y. Aloni, D. Michaeli, P. Weinberger-Ohara, R. Mayer, S. Braun, E. de Vroom, G.A. van der Marel, J.H. vanBoom, and M. Benziman Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid Nature 325 6101 1987 279 281
10. P. Ross, R. Mayer, H. Weinhouse, D. Amikam, Y. Huggirat, M. Benziman, E. de Vroom, A. Fidder, P. de Paus, and L.A. Sliedregt The cyclic diguanylic acid regulatory system of cellulose synthesis in Acetobacter xylinum. Chemical synthesis and biological activity of cyclic nucleotide dimer, trimer, and phosphorothioate derivatives J. Biol. Chem. 265 31 1990 18933 18943
11. R. Hengge Principles of c-di-GMP signalling in bacteria Nat. Rev. Microbiol. 7 4 2009 263 273
12. V.T. Lee, J.M. Matewish, J.L. Kessler, M. Hyodo, Y. Hayakawa, and S. Lory A cyclic-di-GMP receptor required for bacterial exopolysaccharide production Mol. Microbiol. 65 6 2007 1474 1484
13. M. Merighi, V.T. Lee, M. Hyodo, Y. Hayakawa, and S. Lory The second messenger bis-(3′-5′)-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa Mol. Microbiol. 65 4 2007 876 895
14. D.K.R. Karaolis, T.K. Means, D. Yang, M. Takahashi, T. Yoshimura, E. Muraille, D. Philpott, J.T. Schroeder, M. Hyodo, Y. Hayakawa, B.G. Talbot, E. Brouillette, and F. Malouin Bacterial c-di-GMP is an immunostimulatory molecule J. Immunol. 178 4 2007 2171 2181
15. D.L. Burdette, K.M. Monroe, K. Sotelo-Troha, J.S. Iwig, B. Eckert, M. Hyodo, Y. Hayakawa, and R.E. Vance STING is a direct innate immune sensor of cyclic di-GMP Nature 478 7370 2011 515 518
16. K. Parvatiyar, Z. Zhang, R.M. Teles, S. Ouyang, Y. Jiang, S.S. Iyer, S.A. Zaver, M. Schenk, S. Zeng, W. Zhong, Z.-J. Liu, R.L. Modlin, Y.-J. Liu, and G. Cheng The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response Nat. Immunol. 13 12 2012 1155 1162
17. A. Le Bon, V. Durand, E. Kamphuis, C. Thompson, S. Bulfone-Paus, C. Rossmann, U. Kalinke, and D.F. Tough Direct stimulation of T cells by type I IFN enhances the CD8 + T cell response during cross-priming J. Immunol. 176 8 2006 4682 4689
18. D.K.R. Karaolis, M.W. Newstead, X. Zeng, M. Hyodo, Y. Hayakawa, U. Bhan, H. Liang, and T.J. Standiford Cyclic Di-GMP stimulates protective innate immunity in bacterial pneumonia Infect. Immun. 75 10 2007 4942 4950
19. H. Yan, X. Wang, R. KuoLee, and W. Chen Synthesis and immunostimulatory properties of the phosphorothioate analogues of cdiGMP Bioorg. Med. Chem. Lett. 18 20 2008 5631 5634
20. D.-L. Hu, K. Narita, M. Hyodo, Y. Hayakawa, A. Nakane, and D.K.R. Karaolis c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection Vaccine 27 35 2009 4867 4873
21. H. Yan, R. KuoLee, K. Tram, H. Qiu, J. Zhang, G.B. Patel, and W. Chen 3′,5′-cyclic diguanylic acid elicits mucosal immunity against bacterial infection Biochem. Biophys. Res. Commun. 387 3 2009 581 584
22. + cells and strong mucosal and systemic antibody responses in mice Vaccine 29 31 2011 4973 4982
23. P.M. Gray, G. Forrest, T. Wisniewski, G. Porter, D.C. Freed, J.A. DeMartino, D.M. Zaller, Z. Guo, J. Leone, T.-M. Fu, and K.A. Vora Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities Cell. Immunol. 278 1-2 2012 113 119
24. S.M. McWhirter, R. Barbalat, K.M. Monroe, M.F. Fontana, M. Hyodo, N.T. Joncker, K.J. Ishii, S. Akira, M. Colonna, Z.J. Chen, K.A. Fitzgerald, Y. Hayakawa, and R.E. Vance A host type I interferon response is induced by cytosolic sensing of bacterial second messenger cyclic-di-GMP J. Exp. Med. 206 9 2009 1899 1911
25. K. Kogure, H. Akita, Y. Yamada, and H. Harashima Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system Adv. Drug Deliv. Rev. 60 4-5 2008 559 571
26. T. Nakamura, H. Akita, Y. Yamada, H. Hatakeyama, and H. Harashima A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications Acc. Chem. Res. 45 7 2012 1113 1121
27. B. Guy The perfect mix: recent progress in adjuvant research Nat. Rev. Microbiol. 5 7 2007 505 517
28. S.T. Agnandi et al. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children N. Engl. J. Med. 365 20 2011 1863 1875
29. Y. Sato, H. Hatakeyama, Y. Sakurai, M. Hyodo, H. Akita, and H. Harashima A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo J. Control. Release 163 3 2012 267 276
30. N.S. Templeton Cationic liposome-mediated gene delivery Biosci. Rep. 22 2 2002 283 295
31. G. Hartmann, G.J. Weiner, and A.M. Krieg CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells Proc. Natl. Acad. Sci. U. S. A. 96 16 1999 9305 9310
32. M.J. Newman, J.-Y. Wu, B.H. Gardner, K.J. Munroe, D. Leombruno, J. Recchia, C.R. Kensil, and R.T. Coughlin Saponin adjuvant induction of ovalbumin-specific CD8 + cytotoxic T lymphocyte responses J. Immunol. 148 8 1992 2357 2362
33. T. Tanaka, A. Legat, E. Adam, J. Steuve, J.S. Gatot, M. Vandenbranden, L. Ulianov, C. Lonez, J.M. Ruysschaert, E. Muralle, M. Tuynder, M. Goldman, and A. Jacquet DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4 Eur. J. Immunol. 38 5 2008 1351 1357
34. W. Yan, W. Chen, and L. Huang Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine J. Control. Release 130 1 2008 22 28